Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies

Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies

Julia Dvorkin,1,2 Julián De Luca,1 Damian Alvarez-Paggi,1,2 Mauricio T Caballero1,2 1Fundación INFANT, Buenos Aires, Argentina; 2Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, ArgentinaCorrespondence: Mauricio T Caballero, Fundación INFANT, Gavilán 94, Buenos Air...

Full description

Bibliographic Details
Main Authors: Dvorkin J, De Luca J, Alvarez-Paggi D, Caballero MT
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:Infection and Drug Resistance
Subjects:
respiratory syncytial virus
vaccines
prevention
antivirals
therapeutics
Online Access:https://www.dovepress.com/responding-to-higher-than-expected-infant-mortality-rates-from-respira-peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/responding-to-higher-than-expected-infant-mortality-rates-from-respira-peer-reviewed-fulltext-article-IDR

Similar Items